The Pet Industry Joint Advisory Council (PIJAC) recently announced that it has joined the Centers for Disease Control (CDC) and the Department of Health and Human Services (HHS) in fighting antimicrobial resistance (AMR).
The AMR Challenge is a joint effort to encourage governments and private industry to make commitments to reduce AMR through various means. As part of the joint AMR Challenge, PIJAC is working with the pet care community to develop and establish a document, known as Recommendations for Judicious Use of Antimicrobials in Companion Animal Care, intended to address antimicrobial use and outline best practices for the industry. PIJAC also intends to develop educational materials and to provide outreach and education to the pet care community and the general public on the subject of antimicrobial use.
Antimicrobial resistance (AMR) threatens the world’s progress in healthcare, food production, and even life expectancy and affects both humans and animals. When microorganisms are exposed to antimicrobial drugs, such as antibiotics, they may develop a resistance to that drug. Microorganisms that have developed a resistance become harder to treat using those same drugs. Microorganisms that have developed a resistance to most known treatment options are commonly known as “superbugs” and can pose a serious risk to whatever they infect due to their difficulty in treating.
To learn more about PIJAC’s efforts to combat AMR, read the full release.